https://www.marketscreener.com/quote/stock/ALZAMEND-NEURO-INC-123731313/news/Alzamend-Neuro-Submits-IND-Application-for-a-Phase-IIA-Clinical-Trial-in-Major-Depressive-Disorder-P-45124758/?utm_source=telegram&utm_medium=social&utm_campaign=share